Skip to main content

Table 1 Impact of confounding by gender, age, and comorbidity on the association between GEC and mortality of cirrhosis patients, estimated with Cox proportional hazards regression.

From: The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study

  

Crude HR (95% CI)

Adjusted HR (95% CI)

GEC < 1.75 mmol/min

   
 

GEC, per 0.5 mmol/min

0.74 (0.59–0.92)

0.64 (0.51–0.81)

 

Male vs. female

1.31 (1.06–1.63)

1.41 (1.13–1.76)

 

Age, per decade

1.22 (1.11–1.35)

1.20 (1.09–1.32)

 

Comorbidity, CCI ≥ 1 vs. 0

1.40 (1.11–1.78)

1.37 (1.08–1.75)

GEC ≥ 1.75 mmol/min

   
 

GEC, per 0.5 mmol/min

0.79 (0.59–1.05)

0.80 (0.60–1.08)

 

Male vs. female

1.46 (0.87–2.46)

1.44 (0.86–2.43)

 

Age, per decade

1.28 (1.07–1.52)

1.23 (1.02–1.48)

 

Comorbidity, CCI ≥ 1 vs. 0

1.59 (1.08–2.35)

1.42 (0.95–2.12)

  1. Comorbidity is defined by the Charlson comorbidity index (CCI). Associations are expressed as hazard ratios (HR) and presented without adjustment (Crude HR) and with adjustment for the potential confounders.